Kabiven

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, the active ingredients in Kabiven, are a parenteral nutrition presented as a solution for intravenous infusion for intravenous use. It supplies essential amino acids to patients who cannot receive enteral feeding.

GNH USA supplies Kabiven as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Kabiven is an amino acid solution used in parenteral nutrition to meet protein and metabolic needs when enteral feeding is not possible. - Parenteral nutrition for patients who cannot receive enteral feeding: Provides essential amino acids when oral or tube feeding is contraindicated. - Critical illness or postoperative care: Supports protein synthesis and metabolic demands in critically ill or postoperative patients. - Severe malnutrition: Helps meet amino acid requirements in patients with severe malnutrition when enteral routes are unsuitable.

Kabiven may be associated with several infusion‑related and metabolic reactions.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels during infusion. - Electrolyte imbalance: changes in serum potassium, calcium, or phosphate. - Phlebitis at infusion site: irritation or inflammation of the vein. - Mild nausea: transient gastrointestinal discomfort. - Fever: low‑grade temperature rise.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate intervention. - Severe metabolic acidosis: significant drop in blood pH. - Renal dysfunction: impaired kidney function potentially exacerbated by high amino acid load. - Sepsis related to catheter: bloodstream infection associated with the infusion line.

When using Kabiven, clinicians should observe several safety measures. - Renal impairment: monitor renal function and adjust infusion rate as needed. - Liver disease: assess hepatic function before initiating therapy. - Electrolyte disorders: correct existing imbalances prior to infusion. - Hyperosmolar solutions: ensure appropriate dilution and controlled infusion speed. - Pregnancy and lactation: use only if the anticipated benefit outweighs potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with other medications or solutions; awareness of these interactions helps prevent complications.

Major Interactions (Avoid): - Concurrent high‑dose potassium supplements: risk of hyperkalemia. - Other parenteral nutrition solutions: may cause incompatibility or precipitation. - Certain antibiotics (e.g., aminoglycosides) when mixed: precipitation risk.

Moderate Interactions (Monitor Closely): - Diuretics: may affect fluid and electrolyte balance; monitor electrolytes. - Insulin therapy: monitor glucose levels closely due to potential hyperglycemia.